Trials / Terminated
TerminatedNCT01455948
Canadian Health Economics, Outcome, and Effectiveness Comparison of Treatment in Patients With Chronic Rhinosinusitis
Canadian Health Economics, Health Outcome, and Effectiveness Comparison of Treatment of the Frontal Sinus Ostium and Recess and Other Sinuses With Functional Endoscopic Sinus Surgery (FESS) or Balloon Sinuplasty in Patients With Chronic Sinusitis (CRS)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Integra LifeSciences Corporation · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The economic, patient related outcome, and effectiveness of balloon sinuplasty in the treatment of CRS patients with frontal and other sinus disease in the Canadian healthcare environment is not known at this time. This study will evaluate the impact of balloon sinuplasty and traditional FESS treatment on CRS patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Relieva Balloon Sinuplasty™ System | Catheter-based devices used to dilate blocked paranasal sinus ostia (openings). |
| PROCEDURE | Functional Endoscopic Sinus Surgery | Specialized probes are used to cannulate closed ostia (openings), and small forceps are used to resect periostial bone and tissue to enlarge the sinus ostia. |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2011-10-20
- Last updated
- 2024-07-11
Locations
8 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01455948. Inclusion in this directory is not an endorsement.